<DOC>
	<DOCNO>NCT01722461</DOCNO>
	<brief_summary>This prospective , multi-center , randomize , double-blinded study . Subjects enrol randomly assign receive either active treatment axillary hyperhidrosis Ulthera System axillas , sham treatment , also Ulthera System energy setting device set deliver ultrasound energy . Subjects randomize 2:1 ratio , 2 subject randomize active treatment every one subject randomize sham treatment . Subjects receive 2 study treatment 30 day apart . Subjects study personnel conduct efficacy measure blind assign treatment group . The study hypothesis subject active treatment group great reduction underarm sweating compare sham group measure quality life questionnaire . All subject undergo follow-up assessment 14 day 30 day date first study treatment , 14 day , 30 day , 3 month 6 month date second study treatment . Subjects active treatment group also undergo follow-up assessment 9 month 12 month date second study treatment .</brief_summary>
	<brief_title>A Study Ulthera® System Treatment Axillary Hyperhidrosis</brief_title>
	<detailed_description />
	<mesh_term>Hyperhidrosis</mesh_term>
	<criteria>Male female , age 18 year old . Subject good health . Diagnosis primary focal axillary hyperhidrosis evidence least two standard criterion . At least 50mg 5 min spontaneous rest axillary sweat production axilla measure gravimetrically A HDSS score 3 4 Willingness comply study visit requirement Female subject childbearing potential must negative urine pregnancy test result must lactate Visit 1 Female subject 40 year age must mammogram last 2 year Has dermal disorder include infection anticipate treatment site either axilla . Has axillary injection botulinum toxin last year . Has expect use botulinum toxin treatment disease study period . Has know allergy starch powder , iodine , lidocaine . Has secondary hyperhidrosis Has previous surgical treatment hyperhidrosis Has prior miraDry treatment axillary hyperhidrosis . Has use prescription antiperspirant last 14 day plan use study period . Inability withhold use nonstudysupplied antiperspirant deodorant Unwillingness wash studysupplied antiperspirant abstain use 72 hour prior treatment assessment . History previous Ultherapy™ treatment axilla . Has history bleed disorder Has use cholinomimetics , anticholinergic , oral herbal medicine treatment hyperhidrosis past 4 week . Is prisoner incarceration . Is participate another clinical trial involve use investigational device drug ( last 30 day . ) Has history cancer ( exception ) , lymphectomy , plan lymphectomy . Has pacemaker electronic implant . Requires supplemental oxygen . Has use antiplatelet agent / Anticoagulants ( Coumadin , Pradaxa , Heparin , Plavix ) past 6 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Excessive underarm sweating</keyword>
</DOC>